| Application no. and date | 12188230.2 (espacenet) (Federated) (European Patent Register), 20081031 | | Patent/reg. no. and date | DK/EP 2567709, 20171227 | | Publication date | 20130313 | | Priority no. and date | US 984827 P, 20071102 | | EP pub. no. and date |
EP 2567709 20130313 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | P64120DK01 | | Inventor | ETTENBERG, Seth, 54 Clinton Road
Melrose, MA 02176, US,
Cong, Feng, 115 West Squantum, Apt. 712
Quincy, MA 02171, US,
Rangwala, Shamina M., 38 Kilsyth Road, Apt. 33
Brookline, MA 02445, US,
Guth, Sabine, Kleinhüningerstrasse 210
4057 Basel, CH | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) | | Title | Molekyler og fremgangsmåder til modulering af lav-densitets-lipoprotein receptor-beslægtet protein 6 (LRP6) | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
